一种基于过敏的方法来治疗面膜粒状瘤:叙述性审查
Vikram N Sahni1, Rebecca Yim2, Aamir Amanullah3
1From the University of Utah Health, Department of Dermatology, Salt Lake City, Utah, USA.
Dermatitis : contact, atopic, occupational, drug
|September 19, 2025
概括
过敏可以引发口面颗粒状 (OFG) 疾病. 避免识别过敏原往往会改善OFG症状,支持贴片测试和饮食改变以更好地管理.
科学领域:
- 皮肤病学 皮肤病学
- 过敏 免疫学 免疫学
背景情况:
- 面膜颗粒状 (OFG) 疾病与过敏有着不断变化的关系.
- 在OFG中经常报告接触过敏,但避免过敏原的有效性仍然不清楚.
- 最近还没有进行全面的评估,评估OFG中对过敏原的避免.
研究的目的:
- 审查和综合现有的文献,对对抗过敏原避开在 orofacial 颗粒状疾病的影响.
- 通过补丁测试来识别涉及OFG的常见过敏原.
- 评估过敏原避免策略在管理OFG.报告的有效性.
主要方法:
- 系统的文献搜索确定了46项研究 (案例报告,系列,试验,队列研究) 关于在OFG中避免过敏原.
- 分析了158名患者的贴片测试结果,以确定经常报告的过敏原.
- 审查医生和患者报告的结果和口腔疾病严重程度得分,以评估治疗的有效性.
主要成果:
- 通常识别的过敏原包括肉/肉,草/植物产品,酸,酸,,和香味.
- 在171名患者中试验了对过敏原的避免,其中123人 (71%) 报告了一定程度的改善.
- 由于缺乏经过验证的评分系统,因此需要依赖主观的结果措施.
结论:
- 目前的文献支持贴片测试和过敏原避免/消除饮食,以改善敏感个体的OFG.
- 需要进行进一步的受控研究,以严格评估避免过敏原对OFG的影响.
- 对于具有阳性补丁测试的耐火性OFG,建议作为多模式治疗方法的一部分进行过敏原避免试验.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.4K
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.3K
相关概念视频
02:06Allergic Reactions
32.1K
Overview
32.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K